Skip to main content

Advertisement

Log in

Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

A significant number of clinical practice guidelines (CPGs) about the treatment of acne vulgaris in adolescents and adults have been published worldwide. However, little is known about the quality of CPGs in this field. The aim of this study was to appraise the methodological quality of published acne vulgaris CPGs. We performed a systematic review of published CPGs on acne vulgaris therapy from July 2002 to July 2012. Three reviewers independently assessed each CPG using the AGREE II instrument. A standardized score was calculated for each of the six domains. Our search strategy identified 103 citations but just six met our inclusion criteria. Agreement among reviewers was very good: 0.981. The domains that scored better were: “scope and purpose” and “clarity and presentation”. Those that scored worse were “stakeholder involvement”, “rigor of development”, and “applicability”. The European and the Malaysian CPGs were the only recommended with no further modifications. In addition, the Mexican, Colombian and the United States guidelines were recommended with provisos, with lower scores regarding stakeholder involvement, rigor of development and applicability. Only two guidelines clearly reported outcome measures for evaluating efficacy or included quality of life outcomes. CPGs varied regarding the consideration of light/laser therapy or consideration of complementary/alternative medicines. None of them included cost considerations of drugs such as systemic isotretinoin. In conclusion, published acne vulgaris CPGs for acne therapy vary in quality with a clear need to improve their methodological rigor. This could be achieved with the adherence to current CPGs development standards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Agence Française de Sécurité Sanitaire des Produits de Santé (2007) Recommandations de bonne pratique traitement de l’acné par voie locale et générale. Agence Française de Sécurité Sanitaire des Produits de Santé. http://ansm.sante.fr/var/ansm_site/storage/original/application/f8a2a78ecb307240d64d20dfbe8a429b.pdf. Accessed July 2012

  2. Agency for Healthcare Research and Quality (2012) Guideline Summary NGC-5809, Acne. http://www.guideline.gov/summary/summary.aspx?doc_id=11030&nbr=005809&string=ACNE. Accessed Jul 2012

  3. Alonso-Coello P, Irfan A, Solà I, Gich I, Delgado-Noguera M, Rigau D, Tort S, Bonfill X, Burgers J, Schunemann H (2010) The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 19:e58

    PubMed  Google Scholar 

  4. Alonso P, Bonfill X (2007) Guías de práctica clínica (II): búsqueda y valoración crítica. Radiologia 49:23–27

    Article  CAS  PubMed  Google Scholar 

  5. Archer CB, Cohen SN, Baron SE, British Association of Dermatologists and Royal College of General Practitioners. (2012) Guidance on the diagnosis and clinical management of acne. Clin Exp Dermatol 37 Suppl 1:1–6

    Google Scholar 

  6. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L, Consortium ANS (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63:1308–1311

    Google Scholar 

  7. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B,Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. (2010) AGREE II: advancing guideline development,reporting, and evaluation in health care. Prev Med 51:421–424

    Google Scholar 

  8. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Graham ID, Hanna SE, Makarski J, Consortium ANS (2010) Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ 182:1045–1052

    Article  PubMed Central  PubMed  Google Scholar 

  9. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J, Consortium ANS (2010) Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ 182:E472–E478

    Article  PubMed Central  PubMed  Google Scholar 

  10. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.(2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182: E839–842

  11. Centre Belge d′ïnformation Pharmacotherapeutique (2005) Traitement de l’acne vulgaire. http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F32F07D. Accessed July 2012

  12. Dréno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H, Acne EEGoOAi (2004) European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 14:391–399

    PubMed  Google Scholar 

  13. Dréno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, Layton A (2006) An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 16:565–571

    PubMed  Google Scholar 

  14. Francke AL, Smit MC, de Veer AJ, Mistiaen P (2008) Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 8:38

    Article  PubMed Central  PubMed  Google Scholar 

  15. Garcia-Gutierrez JF, Bravo-toledo R (2001) Guias de practica clinica en internet. Aten Primaria 28:74–79

    Article  CAS  PubMed  Google Scholar 

  16. Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (2010) Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. Br J Dermatol 162:1172–1179

    Article  CAS  PubMed  Google Scholar 

  17. Grilli R, Magrini N, Penna A, Mura G, Liberati A (2000) Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355:103–106

    Article  CAS  PubMed  Google Scholar 

  18. GUIPCAR Group (2001) Clinical Practice Guideline for the Management of Rheumatoid Arthritis in Spain. Spanish Society of Rheumatology. Madrid, pp: 301

  19. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, Group GW (2008) What is “quality of evidence” and why is it important to clinicians? BMJ 336:995–998

    Article  PubMed Central  PubMed  Google Scholar 

  20. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926

    Article  PubMed Central  PubMed  Google Scholar 

  21. Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter AO (1997) Canadian physicians’ attitudes about and preferences regarding clinical practice guidelines. CMAJ 156:1715–1723

    CAS  PubMed Central  PubMed  Google Scholar 

  22. Hoomans T, Evers SM, Ament AJ, Hübben MW, van der Weijden T, Grimshaw JM, Severens JL (2007) The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health 10:305–316

    Article  PubMed  Google Scholar 

  23. Hospital General de Mexico (2005) Guias de Diagnostico y Tratamiento. Acne vulgar. http://www.hgm.salud.gob.mx/descargas/pdf/area_medica/derma/guias/acne_vulgar.pdf. Accessed June 2012

  24. Institute of Medicine (1990) Clinical Practice Guidelines: Directions for a New Program. National Academy Press, Washington DC

  25. Institute of Medicine (2011) Clinical Practice Guidelines We Can Trust. National Academy Press, Washington DC

  26. Kalla AA, Stanwix A, Gotlieb D, Asherson RA, Mody GM (2003) Rheumatoid arthritis: clinical guideline 2003. S Afr Med J 93:991–1012

    CAS  PubMed  Google Scholar 

  27. Kaminsky A, Saraceno E, Airaudo M et al (2005) Consenso sobre Acné. Sociedad Argentina de Dermatología. http://www.sad.org.ar/revista/pdf/acne.pdf. Accessed July 2012

  28. Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP (2012) Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin 30:99–106 Viii–ix

    Article  CAS  PubMed  Google Scholar 

  29. Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111–123

    Article  CAS  PubMed  Google Scholar 

  30. Kubba R, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M, Dhar S, Criton S, Fernandez R, Kanwar AJ, Khopkar U, Kohli M, Kuriyipe VP, Lahiri K, Madnani N, Parikh D, Pujara S, Rajababu KK, Sacchidanand S, Sharma VK, Thomas J, (IAA) IAA (2009) Acne in India: guidelines for management—IAA consensus document. Indian J Dermatol Venereol Leprol 75(Suppl 1):1–62

    PubMed  Google Scholar 

  31. Kung J, Miller RR, Mackowiak PA (2012) Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any progress. Arch Intern Med 172:1628–1633

    Article  PubMed  Google Scholar 

  32. Ledingham J, Deighton C, British Society for Rheumatology Standards GiaAWG (2005) Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44:157–163

    Google Scholar 

  33. Malaysia Ministry of Health, Dermatological Society of Malaysia, Academy of Medicine Malaysia (2012) Clinical practice guidelines: Management of acne. http://www.moh.gov.my. Accessed July 2012

  34. Mikkelsen CS, Hansen SR, Kroon S (2011) Local treatment of acne. Tidsskr Nor Laegeforen 131:33–34

    Article  PubMed  Google Scholar 

  35. Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, Fluhr J, Gieler U, Hartwig R, Meigel EM, Möller S, Ochsendorf F, Podda M, Rabe T, Rzany B, Sammain A, Schink S, Zouboulis CC, Gollnick H, (BVDD) GSoDDatAoGD (2010) S2 k-guideline for therapy of acne. J Dtsch Dermatol Ges 8(Suppl 2):s1–s59

    PubMed  Google Scholar 

  36. Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivković MV, Zouboulis CC, Gollnick H, Forum ED (2012) European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 26(Suppl 1):1–29

    Article  PubMed  Google Scholar 

  37. Nast A, Rosumeck S, Sammain A, Sporbeck B, Rzany B (2012) Methods report on the development of the European S3 guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 26(Suppl 1):e1–e41

    Article  PubMed  Google Scholar 

  38. National Institute for Clinical Excellence (2002) Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis: technology appraisal guidance no. http://www.nice.org.uk. Accessed July 2012

  39. Niessen LW, Grijseels E, Koopmanschap M, Rutten F, Health DMo (2007) Economic analysis for clinical practice–the case of 31 national consensus guidelines in the Netherlands. J Eval Clin Pract 13:68–78

    Article  PubMed  Google Scholar 

  40. Orozco B, Campo ME, Anaya LA, Atuesta J, Ávila MJ, Balcázar LF et al (2011) Guías colombianas para el manejo del acné: una revisión basada en la evidencia por el Grupo Colombiano de Estudio en Acné. Rev Asoc Colomb Dermatol 19:129–158

    Google Scholar 

  41. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O’Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC (2004) Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 364:2188–2195

    Article  CAS  PubMed  Google Scholar 

  42. Piquero-Martin J (2005) Libro Online de Dermatologia http://www.dermatologiapediatrica.net/sitio/libro-online-especialistas-73.html. Accessed July 2012

  43. Poitras S, Rossignol M, Avouac J, Avouac B, Cedraschi C, Nordin M, Rousseaux C, Rozenberg S, Savarieau B, Thoumie P, Valat JP, Vignon E, Hilliquin P (2010) Management recommendations for knee osteoarthritis: how usable are they? Jt Bone Spine 77:458–465

    Article  Google Scholar 

  44. Poolman RW, Verheyen CC, Kerkhoffs GM, Bhandari M, Schünemann HJ, Group IE-BOSW (2009) From evidence to action: Understanding clinical practice guidelines. Acta Orthop 80:113–118

    Google Scholar 

  45. Purriños L (2011) Acne. Fisterra Guias Clinicas http://www.fisterra.com/guias-clinicas/acne/. Accessed July 2012

  46. Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P, BoTotGI Network (2012) Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 156:525–531

    Article  PubMed  Google Scholar 

  47. Ramos-e-Silva M, Carneiro SC (2009) Acne vulgaris: review and guidelines. Dermatol Nurs 21:63–68 quiz 69

    PubMed  Google Scholar 

  48. Secretaria de Salud, Gobierno de Mexico (2009) Resumen de evidencias y recomendaciones. Diagnostico y tratamiento de acné. Guía de Practica Clínica. http://cenetec.salud.gob.mx/interior/gpc.html. accessed July 2012

  49. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J (1999) Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281:1900–1905

    Article  CAS  PubMed  Google Scholar 

  50. Sinclair W, Jordaan HF, Global Alliance to Improve Outcomes in Acne (2005) Acne Guideline 2005 Update. S Afr Med J 95:881–892

  51. Instituto Hondureño de Seguridad Social (2009) Guias Clinicas del II y III Nivel. Tomo III Medicina Interna. Acne. http://apps.who.int/medicinedocs/documents/s18607es/s18607es.pdf. Accessed June 2012

  52. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R, Association AAoDAAoD (2007) Guidelines of care for acne vulgaris management. J Am Acad Dermatol 56:651–663

    Article  PubMed  Google Scholar 

  53. Tan JK, Wolfe BJ, Bulatovic R, Jones EB, Lo AY (2010) Critical appraisal of quality of clinical practice guidelines for treatment of psoriasis vulgaris, 2006–2009. J Invest Dermatol 130:2389–2395

    Article  CAS  PubMed  Google Scholar 

  54. Torres V, Gollnick H, Campo MH, de-Castro L, Cordero A, Talarico S, Gomez M et al (2008) Reporte final de la Primera Reunión de la Alianza Global para mejorar el Tratamiento del Acné (Global Alliance to Improve Outcomes in Acne). Capítulo Latinoamérica. “GALA” Cartagena, Colombia. Mayo 6–7, 2007. Dermatología Rev Mex 52:S1–S40

    Google Scholar 

  55. Vale L, Thomas R, MacLennan G, Grimshaw J (2007) Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ 8:111–121

    Article  PubMed  Google Scholar 

  56. Wimpenny P, van Zelm R (2007) Appraising and comparing pressure ulcer guidelines. Worldviews Evid Based Nurs 4:40–50

    Article  PubMed  Google Scholar 

  57. Zaenglein AL, Thiboutot DM (2006) Expert committee recommendations for acne management. Pediatrics 118:1188–1199

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Dr. Gloria Sanclemente is a PhD Candidate of the Universitat Autònoma de Barcelona, Spain. This work was supported by the Group of Investigative Dermatology-GRID (University of Antioquia), Medellin, Colombia, which is an academic research group with no affiliation with any pharmaceutical company.

Conflict of interest

Dr. Gloria Sanclemente has received speaker fees and support for attending meetings from pharmaceutical companies that sell acne vulgaris products such as Galderma and Roche laboratories, and from other companies not involved with acne products such as Pfizer and Jannsen-Cilag.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gloria Sanclemente.

Appendix [4, 15]

Appendix [4, 15]

Databases searched for CPGs in Acne Vulgaris.

  1. 1.

    National Guideline Clearinghouse (NGC) http://www.guideline.gov/.

  2. 2.

    Canadian Medical Association (CMA) http://www.cma.ca/.

  3. 3.

    Scottish Intercollegiate Guidelines Network (SIGN) http://www.sign.ac.uk.

  4. 4.

    New Zealand Guidelines Group (NZGG) http://www.nzgg.org.nz/.

  5. 5.

    TRIP database http://www.tripdatabase.com/.

  6. 6.

    MEDLINE http://www.pubmed.gov/.

  7. 7.

    NeLH National Electronic Library for Health https://www.evidence.nhs.uk/.

  8. 8.

    Handbook of United Kingdom and European clinical guidelines for primary and shared care http://www.eguidelines.co.uk/about_guidelines.php.

  9. 9.

    AEZQ/AQuMed German Agency for Quality in Medicine http://www.aezq.de/.

  10. 10.

    CISMeF Catalog and Index of French-language health resources http://www.chu-rouen.fr/cismef/cismefeng.html.

  11. 11.

    Francophones/Catalog and Index of French -language health resources http://www.chu-rouen.fr/cismef/cismefeng.html.

  12. 12.

    NICE National Institute for Clinical Excellence http://www.nice.org.uk/.

  13. 13.

    GPC de la American Academy of Pediatrics http://www.aap.org/en-us/professional-resources/practice-support/quality-improvement/Pages/Clinical-Practice-Guidelines.aspx.

  14. 14.

    GPC Universidad California http://compliance.uclahealth.org/body.cfm?id=23.

  15. 15.

    Guidelines International Network http://www.g-i-n.net.

  16. 16.

    Grading of Recommendations Assessment, Development and Evaluation http://www.gradeworkinggroup.org/.

  17. 17.

    ICSI Institute for Clinical Systems Improvement http://www.icsi.org.

  18. 18.

    South African Departament of Health http://www.doh.gov.za/.

  19. 19.

    AHRQ Agency for Healthcare Research and Quality http://www.ahrq.gov.

  20. 20.

    ACP American College of Physicians http://www.acponline.org.

  21. 21.

    Singapore Ministery of health Guidelines http://www.moh.gov.sg/content/moh_web/home/Publications/guidelines/cpg.html.

  22. 22.

    CINAHL Cumulative Index to Nursing & Allied Health Literature.

  23. 23.

    Cochrane Library Plus http://www.update-software.com/clibplus/clibpluslogon.htm.

  24. 24.

    WHOLIS Sistema de información de la Biblioteca de la OMS http://www.who.int/library/databases/wholis_tutorial/es/.

  25. 25.

    MEDCARIB Literatura del Caribe en Ciencias de la Salud http://liscuba.sld.cu/index.php?P=FullRecord&ID=1647.

  26. 26.

    ADOLEC Salud en adolescencia http://www.adolec.org.ni/php/index.php.

  27. 27.

    PAHO Catálogo de la Biblioteca Sede de la OPS http://www.paho.org/.

  28. 28.

    LILACS http://lilacs.bvsalud.org/.

  29. 29.

    European Academy of Dermatology and Venereology http://www.eadv.org/.

  30. 30.

    American Aacademy of Dermatology http://www.aad.org/.

  31. 31.

    British Association of Dermatology (BAD) http://www.bad.org.uk.

  32. 32.

    American Academy of Pediatrics http://www.aap.org.

  33. 33.

    Associazione Italiana Dermatologi Ambulatoriali http://www.aida.it/.

  34. 34.

    Australasian College of Dermatologists http://www.dermcoll.asn.au/.

  35. 35.

    Danish Society of Dermatology http://www.danderm-pdv.is.kkh.dk/.

  36. 36.

    Dermatology Foundation http://dermatologyfoundation.org/.

  37. 37.

    Internet Dermatology Society http://telemedicine.org/.

  38. 38.

    Pacific Dermatologic Association http://www.pacificderm.org/.

  39. 39.

    Société Française de Dermatologie http://www.sfdermato.org/.

  40. 40.

    Society for Investigative Dermatology http://www.sidnet.org/.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanclemente, G., Acosta, JL., Tamayo, ME. et al. Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument. Arch Dermatol Res 306, 269–277 (2014). https://doi.org/10.1007/s00403-013-1394-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-013-1394-x

Keywords

Navigation